Shivangi Awasthi
Affiliations: | Pharmaceutical Sciences | University of Maryland School of Pharmacy |
Google:
"Shivangi Awasthi"Mean distance: (not calculated yet)
Parents
Sign in to add mentorDavid Robinson Goodlett | grad student | 2013-2018 | University of Maryland School of Pharmacy |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zhang X, Nguyen KD, Rudnick P, et al. (2019) Quantitative mass spectrometry to interrogate proteomic heterogeneity in metastatic lung adenocarcinoma and validate a novel somatic mutation CDK12-G879V. Molecular & Cellular Proteomics : McP |
Xhang X, Nguyen KDP, Rudnick P, et al. (2019) Abstract 4528: Quantitative mass spectrometry to interrogate proteomic heterogeneity in metastatic lung adenocarcinoma and validate a novel somatic mutation CDK12-G879V Cancer Research. 79: 4528-4528 |
Awasthi S, Maity T, Oyler BL, et al. (2018) Dataset describing the development, optimization and application of SRM/MRM based targeted proteomics strategy for quantification of potential biomarkers of EGFR TKI sensitivity. Data in Brief. 19: 424-436 |
Awasthi S, Maity T, Oyler BL, et al. (2018) Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma. Journal of Proteomics |
Zhang X, Maity T, Kashyap MK, et al. (2017) Quantitative tyrosine phosphoproteomics of EGFR tyrosine kinase inhibitor-treated lung adenocarcinoma cells reveals potential novel biomarkers of therapeutic response. Molecular & Cellular Proteomics : McP |
Awasthi S, Zhang X, Maity T, et al. (2017) Abstract 2203: A SRM/MRM based targeted proteomics strategy for absolute quantification of potential biomarkers of TKI sensitivity in EGFR mutated lung adenocarcinoma Cancer Research. 77: 2203-2203 |
Tran BQ, Barton C, Feng J, et al. (2016) Glycosylation characterization of therapeutic mAbs by top- and middle-down mass spectrometry. Data in Brief. 6: 68-76 |
Tran BQ, Barton C, Feng J, et al. (2016) Glycosylation characterization of therapeutic mAbs by top- and middle-down mass spectrometry Data in Brief. 6: 68-76 |
Tran BQ, Barton C, Feng J, et al. (2015) Comprehensive glycosylation profiling of IgG and IgG-fusion proteins by top-down MS with multiple fragmentation techniques. Journal of Proteomics |